1. Home
  2. KE vs FTRE Comparison

KE vs FTRE Comparison

Compare KE & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KE
  • FTRE
  • Stock Information
  • Founded
  • KE 1961
  • FTRE 1996
  • Country
  • KE United States
  • FTRE United States
  • Employees
  • KE N/A
  • FTRE N/A
  • Industry
  • KE Electrical Products
  • FTRE Medical Specialities
  • Sector
  • KE Technology
  • FTRE Health Care
  • Exchange
  • KE Nasdaq
  • FTRE Nasdaq
  • Market Cap
  • KE 451.8M
  • FTRE 469.0M
  • IPO Year
  • KE N/A
  • FTRE N/A
  • Fundamental
  • Price
  • KE $18.85
  • FTRE $5.32
  • Analyst Decision
  • KE Buy
  • FTRE Hold
  • Analyst Count
  • KE 5
  • FTRE 11
  • Target Price
  • KE $22.20
  • FTRE $17.10
  • AVG Volume (30 Days)
  • KE 218.1K
  • FTRE 2.7M
  • Earning Date
  • KE 08-12-2025
  • FTRE 08-11-2025
  • Dividend Yield
  • KE N/A
  • FTRE N/A
  • EPS Growth
  • KE N/A
  • FTRE N/A
  • EPS
  • KE 0.71
  • FTRE N/A
  • Revenue
  • KE $1,536,413,000.00
  • FTRE $2,685,600,000.00
  • Revenue This Year
  • KE N/A
  • FTRE N/A
  • Revenue Next Year
  • KE N/A
  • FTRE $1.36
  • P/E Ratio
  • KE $26.51
  • FTRE N/A
  • Revenue Growth
  • KE N/A
  • FTRE N/A
  • 52 Week Low
  • KE $12.41
  • FTRE $3.97
  • 52 Week High
  • KE $24.45
  • FTRE $28.41
  • Technical
  • Relative Strength Index (RSI)
  • KE 57.97
  • FTRE 49.95
  • Support Level
  • KE $18.46
  • FTRE $3.97
  • Resistance Level
  • KE $19.59
  • FTRE $6.56
  • Average True Range (ATR)
  • KE 0.59
  • FTRE 0.49
  • MACD
  • KE -0.08
  • FTRE 0.10
  • Stochastic Oscillator
  • KE 55.59
  • FTRE 52.12

About KE Kimball Electronics Inc.

Kimball Electronics Inc is a contract electronic manufacturing services company. The company is engaged in producing durable electronics for the automotive, medical, industrial, and public safety end markets. The company's engineering, manufacturing, and supply chain services utilize common production and support capabilities. It is also engaged in producing safety-critical electronic assemblies for its automotive customers. Geographically, it has business units located in the United States, China, Mexico, Poland, Romania, and Thailand. The company derives maximum revenue from Mexico.

About FTRE Fortrea Holdings Inc.

Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: